The chimeric <i>FUS/CREB3l2</i> gene is specific for low‐grade fibromyxoid sarcoma
Ioannis Panagopoulos(Oslo University Hospital), Fredrik Mertens(Lund University), Clelia Tiziana Storlazzi(University of Bari Aldo Moro), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Nils Mandahl(Lund University), Johan Wejde(Karolinska University Hospital), Anders Rydholm(Lund University), Otte Brosjö(Karolinska University Hospital), Jonathan A. Fletcher(Harvard University), Henryk A. Domanski(Lund University), Margareth Isaksson(Lund University), Antonio G. Nascimento(AC Camargo Hospital)
Cited by 215
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716